期刊文献+

ZEB-1在胃癌组织中的表达及临床意义 被引量:2

Expression of ZEB- 1 in Gastric Carcinoma Tissue and Its Clinical Significance
下载PDF
导出
摘要 目的探讨胃癌组织中ZEB-1的表达及意义。方法采用SP免疫组化法、形态计量、统计分析等方法检测ZEB-1蛋白在57例胃癌组织和20例癌旁正常胃组织中的表达情况。结果免疫组织化学结果显示ZEB-1在胃癌组织中呈阳性表达,阳性表达率为82.4%(47/57)明显高于在癌旁正常胃组织的阳性表达率15%(3/20);胃癌组织中ZEB-1的表达与肿瘤分化程度、浸润深度、有无淋巴结转移、临床分期及预后有关(P<0.05),与性别、年龄、肿瘤大小无关(P>0.05)。结论 ZEB-1在胃癌组织中的表达上调可能参与了胃癌的发生发展过程;ZEB-1可能诱导EMT促进胃癌的侵袭和转移;ZEB-1可能作为分子指标,对胃癌的诊断、治疗方案的选择及预后评价提供一定的临床依据。 Objective To investigate ZEB- 1 protein expression in gastric carcinoma tissues and the clinical significance.Methods SP immunohistochemical method, morphometry and statistical analysis were used to detect the ZEB-1 protein expression in 5? gastric tissues and 20 paracan-cerous normal gastric tissues.Results Immunohistochemical staining showed that the positive rates of ZEB-1 protein expression in gastric carcinoma tissues were 82.4% (47/57), while the positive rates of ZEB-1 protein expression in the noimalgastric tissues were 15% (3/20). The expressions of ZEB-1 in the former was significantly higher than that in the latter. We also found that ZEB-1 expression was significantly correlated with the tumor differentiation degree, the depth of invasion, metastasis, clinical stage and prognosis recurrence (P〈0.05),but was not correlated with the sex, the age or the size of the tumor (P〉0.05).Conclusion High expression of ZEB-1 is correlated with the development and progression of the gastric carcinoma; ZEB-1 might also participate in the epithelial-mesenchymal transition of gastric carcinoma, subsequently contributing to the invasion and metastasis; ZEB-l may act as a molecular target, provide a clinical basis for the diagnosis, treatment and prognosis evaluation program for gastric cancer.
作者 彭璇
出处 《湖北民族学院学报(医学版)》 2013年第3期9-11,共3页 Journal of Hubei Minzu University(Medical Edition)
关键词 胃癌组织 ZEB-1 临床病理特征 免疫组织化学 gastric carcinoma tissue ZEB-1 clinical and pathological characteristics immunohistochemistry
  • 相关文献

参考文献11

  • 1徐飚,王建明.胃癌流行病学研究[J].中华肿瘤防治杂志,2006,13(1). 被引量:159
  • 2Spoelstra N S, Manning N G, Higashi Y, et al. The tran- scription factor ZEB1 is aberrantly expressed in aggressive uterine cancers [ J ]. Cancer Res, 2006,66 : 3893- 3902.
  • 3Acloque H, Thiery JP, Nieto MA.The physiology and pa- thology of the EMT.Meeting on the Epithelial-Mesenchy- mal Transition [ J ]. EMBO Rep, 2008,9 (4) : 322 - 6.
  • 4Tse JC, Kalluri R. Mechanisms of metastasis : epithelial- to-mesenchymal ransition and contribution of tumor mi- croenvironment. J Cell Biochem, 2007,101 (4) : 816-29.
  • 5Liu Y,E1-Naggar S,Darling D S,et al. Zebl links epithe- lial - mesenchymal transition and cellular senescence [ J]. Development,2008,135:579-588.
  • 6Vandewalle C, Van Roy F, Berx G. The role of the ZEB family of transcription factors in development and disease [J]. Cell Mol Life Sci,2009,66:773-787.
  • 7Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer[ J] .Cancer Res, 2002,62(2) :1613-1618.
  • 8Eger A, Aigner K,, Sonderegger S, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epi- thelial plasticity in breast cancer ceils [ J ]. Oncogene, 2005,24(14) :2375-2385.
  • 9Cano A, Perez-Moreno MA, Rodrigo I, et al. The tran- scription factor snail controls epithelial -mesenchymal transitions by repressing E- cadherin expression [ J ]. Nat Cell Biol, 2000,2 (2) : 76- 83.
  • 10Perez-Moreno MA, Locascio A, Rodrigo I, et al. A new role for E12/E47 in the repression of E-cadherin ex- pression and epithelial - mesenchymal transitions [ J ]. J Bid Chem,2001,276(29) :27424-27431.

共引文献158

同被引文献27

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部